Profile picture

Doctor Philippe Rouet

Rangueil Hospital of Toulouse, Toulouse (France)
Follow
Logo ESC

Contributor content

sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure,  independent of Mineralocorticoid Receptor Antagonists treatment.
Presentation
sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure, independent of Mineralocorticoid Receptor Antagonists treatment.
A single systemic injection of AAV9-hIGFBP2 prevents left ventricular hypertrophy and dysfunction in metabolic syndrome
Presentation
A single systemic injection of AAV9-hIGFBP2 prevents left ventricular hypertrophy and dysfunction in metabolic syndrome

ESC 365 is supported by